Monday, 31 August 2026European Markets

FINANCIERE MARJOS Stock Was Up By 22.22% Today

Loading stream...

(vianews) - the market ended the session with financiere marjos (finm.pa) jumping 22.22% to €0.11 on tuesday while cac 40 dropped 0.3% to €7,932.82.

financiere marjos's last close was €0.09, 57.14% below its 52-week high of €0.21.

about financiere marjos

financière marjos sa, together with its subsidiaries, engages in the creation, installation, acquisition, and operation of various companies in france and internationally. the company's portfolio includes manufacturing, sales, rental, and maintenance companies. the company was formerly known as clayeux sa and changed its name to financière marjos sa. the company was incorporated in 1957 and is headquartered in paris, france.

earnings per share

as for profitability, financiere marjos has a trailing twelve months eps of €-0.01.

volatility

financiere marjos's last week, last month's, and last quarter's current intraday variation average was a negative 2.22%, a negative 10.35%, and a positive 10.35%.

financiere marjos's highest amplitude of average volatility was 2.22% (last week), 10.35% (last month), and 10.35% (last quarter).

dividend yield

as stated by morningstar, inc., the next dividend payment is on jul 15, 1992, the estimated forward annual dividend yield is 2.93%.

more news about financiere marjos (finm.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com